Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, and repeatable. We have developed the first methodology for continuous industrial production of biologics and cell therapies leveraging microfluidics and 3D printing.
In 2020, the total volume of anthropogenic mass matched the total amount of biomass globally, which means it matched everything that is alive on the planet. We can only expect that this number keeps increasing since it's key to solving humanity's systemic challenges.
But we have to make sure that conquering the great challenges of humanity doesn’t extinguish the planet’s capacity to sustain life.
The current way of biomanufacturing has provided humanity with innumerable solutions. Bioprocessing is the most efficient way to align human advancement with a thriving nature. In order to prevent nature from perishing, we aim to put it at the center of all human activities by incorporating its knowledge system within the process of achieving humanity's prosperity.
Founded in 2016, Stämm mimics nature’s use of laminar flow to down-size a whole biotech facility into an all-in-one, plug & play desktop unit. Our focus is to decentralize bioprocesses and democratize access to biotechnology products, thus freeing our partners to focus on the disruptive discoveries that make an impact on people’s life.
In 2020, the total volume of anthropogenic mass matched the total amount of biomass globally, which means it matched everything that is alive on the planet. We can only expect that this number keeps increasing since it's key to solving humanity's systemic challenges.
But we have to make sure that conquering the great challenges of humanity doesn’t extinguish the planet’s capacity to sustain life.
The current way of biomanufacturing has provided humanity with innumerable solutions. Bioprocessing is the most efficient way to align human advancement with a thriving nature. In order to prevent nature from perishing, we aim to put it at the center of all human activities by incorporating its knowledge system within the process of achieving humanity's prosperity.
Founded in 2016, Stämm mimics nature’s use of laminar flow to down-size a whole biotech facility into an all-in-one, plug & play desktop unit. Our focus is to decentralize bioprocesses and democratize access to biotechnology products, thus freeing our partners to focus on the disruptive discoveries that make an impact on people’s life.
Location: United States, California, San Francisco
Employees: 51-200
Phone: +1 415-770-9510
Total raised: $20M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | High House | high-house... |
| - | Climate Fi... | climatefir... |
| - | Draper Ass... | draper.vc |
| - | Draper Cyg... | drapercygn... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.03.2022 | Series A | $20M | IndieBio |
Mentions in press and media 11
| Date | Title | Description |
| 06.02.2025 | Cultivated Meat: The Future of Food Takes Shape | The world of food is changing. Cultivated meat is at the forefront of this revolution. Companies like Mosa Meat and SuperMeat are leading the charge. They are not just selling products; they are selling a vision. A vision of sustainable, et... |
| 05.02.2025 | Stämm and SuperMeat Partner to Improve Efficiency and Scalability in Cultivated Chicken | Argentine biotechnology company Stämm has partnered with Israeli cultivated meat producer SuperMeat to enhance biomanufacturing processes for cultivated chicken. The collaboration, supported by mutual investor Varana Capital, will focus on ... |
| 15.01.2025 | Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots | Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow bioreactor: the Bioprocessor. SAN FRANCI... |
| 18.07.2023 | Q&A: GRIDX CEO on why Argentina is leading Latin America’s boom in biotech innovation | Argentina, Latin America’s southernmost country, is often characterized by ongoing economic crises and turmoil. But it is also fast becoming an innovation center for biotech: Second only to the US, Argentina is now the main provider of proj... |
| 17.03.2022 | The Week in Agrifoodtech: Licious nets $150m, Bear Robotics raises $81m | Licious, an India e-commerce marketplace for meat, scored $150 million in Series F-plus investment this week, while California’s Bear Robotics bagged $81 million for its robot restaurant servers. Over in agtech, Local Bounti snapped up a ri... |
| 14.03.2022 | Stämm Biotech Secures $17 Million For Desktop Sized Bioreactors | 4 Mins Read Buenos Aires-based Stämm Biotech recently closed a $17 million Series A round to scale its 3-D printing bioreactors aimed at the global cultivated meat sector. This brings the startup’s funding to $20 million. The new investment... |
| 02.03.2022 | OPT Industries secures $15M to advance 3D printing metamaterials design | Novel materials developer and MIT spin-out OPT Industries has raised $15 million in Series A funding to scale up the development of its novel 3D printing metamaterials and products. The capital injection will also be funneled into scaling u... |
| 01.03.2022 | Stämm Biotech Raises $17M in Series A Funding | Stämm, a Buenos Aires, Argentina-based early-stage biotechnology company, raised $17m in Series A funding. The round was led by Varana Capital, with participation from Draper Associates, SOSV’s IndieBio, Decarbonization Consortium, Trillian... |
| 01.03.2022 | Stämm Biotech raises $17M to develop desktop 3D printed bioreactor | Argentinian biotechnology firm Stämm Biotech has reportedly closed a $17 million Series A funding round which will help the company accelerate the development of its next-generation 3D printed bioreactor. The firm is developing its microflu... |
| 15.08.2019 | How Argentina’s GridX is building foodtech and agtech companies with backing from billionaires | It took Matias Peire three years to decide what to do after exiting the video monitoring and processing business he’d created for the broadcast industry. He knew he wanted to make a difference and was tempted by venture capital. But after d... |
Show more